ANI Pharmaceuticals Inc (ANIP NASDAQ) stock market data APIs
$82.0967
0.74(0.9%)
as of December 8, 2025
Try our APIs with
free plan!
ANI Pharmaceuticals Inc Financial Data Overview
Price chart is built with
Anychart
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. It markets, sells, and distributes its products through wholesalers, retail market chains, distributors and specialty pharmacies, group purchasing organizations, specialty pharmacies, hospitals, clinics, and physicians. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.
Prev. Close
82.0967
Open
82.8328
High
83.7039
Low
81.9462
52 wk Range
52.5-99.5
Market Cap
1 827 M
P/E Ratio
50.8375
Shares Outstanding
22 458 K
Revenue
827 M
EPS
2.04
Beta
0.484
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with ANI Pharmaceuticals Inc (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get ANI Pharmaceuticals Inc data using free add-ons & libraries
Get ANI Pharmaceuticals Inc Fundamental Data
ANI Pharmaceuticals Inc Fundamental data includes:
- Net Revenue: 827 M
- EBITDA: 145 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-07
- EPS/Forecast: 1.76
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
ANI Pharmaceuticals Inc News
New
ANI Pharmaceuticals (ANIP): Has the Recent Share Price Pullback Created a Valuation Opportunity?
ANI Pharmaceuticals (ANIP) has pulled back about 10% over the past month and nearly 17% in the past 3 months, giving investors a fresh chance to reassess the stock after last year's strong run. See o...
PRAX Stock Skyrockets 520% in 3 Months: Here's What You Need to Know
Shares of Praxis Precision Medicines PRAX have skyrocketed 519.5% in the past three months. The sharp rally in the stock was largely fueled by encouraging top-line data from two pivotal late-stage stu...
Incyte's Rare Blood Cancer Therapy Gets FDA's Breakthrough Status
Incyte INCY announced that the FDA has granted the Breakthrough Therapy designation to its investigational, first-in-class, mutCALR-targeted monoclonal antibody, INCA033989, to treat patients with ess...
ABSI Stock Up on Initiating Dosing in Androgenetic Alopecia Study
Shares of Absci Corporation ABSI jumped 13.4% on Thursday after the company initiated dosing in an early-to-mid-stage study evaluating its investigational candidate, ABS-201, for androgenetic alopecia...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
